Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

Cardinal Health said Wednesday morning it has agreed ... for $1.2 billion as it piles additional investment into its specialty pharmacy business. Specialty Networks’ software analyzes patient ...

specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory ...

specialty and provider services, as well as pharmacy services. Strategic transactions and organic investments have helped grow Cardinal Health’s specialty solutions business tenfold since 2012.

Jan 30 (Reuters) - Drug distributor Cardinal Health (CAH.N), opens new tab said ... banking on strong demand for costly specialty medicines and branded drugs in its pharmaceuticals unit.

Cardinal Health's pharmaceutical and specialty solutions segment profit increased 7% to $531 million in the second quarter.

Cardinal Health lifts annual profit outlook on strength in specialty medicines unit November ... settled with Walgreens over claims that the pharmacy operator fueled opioid addiction in the ...

Cardinal Health raised its fiscal 2025 EPS guidance to $7.85-$8, citing strong pharma segment performance and specialty integration. The acquisition of GI Alliance and progress in specialty ...

Cardinal Health CEO Jason Hollar recounted the ... in its largest business distributing pharmaceuticals, especially specialty drugs such as for chemotherapy. "The opportunities are immense in ...

U.S. drug distributors are strengthening their position in the specialty ... Group's pharmacy benefit management unit OptumRX in 2024. On an adjusted basis, Cardinal Health reported a profit ...